Approval · Notice of Compliance 10281 · 2009
TECHNELITE: Notice of Compliance 10281
Issued June 15, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10281
- Date
- June 15, 2009
- Company
- Lantheus Mi Canada IncMontreal, Quebec, Canada
- Product type
- Radiopharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- An alternate source of Molybdenum Mo99
- Therapeutic class
- Diagnostic radiopharmaceutical
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TECHNELITE | Not yet assigned | — |
Medicinal ingredients
- TECHNETIUM TC 99M 500 MCI per GEN
- TECHNETIUM TC 99M 750 MCI per GEN
- TECHNETIUM TC 99M 1,000 MCI per GEN
- TECHNETIUM TC 99M 1,250 MCI per GEN
- TECHNETIUM TC 99M 1,500 MCI per GEN
- TECHNETIUM TC 99M 1,750 MCI per GEN
- TECHNETIUM TC 99M 2,000 MCI per GEN
- TECHNETIUM TC 99M 2,500 MCI per GEN
- TECHNETIUM TC 99M 3,000 MCI per GEN
- TECHNETIUM TC 99M 3,500 MCI per GEN
- TECHNETIUM TC 99M 4,000 MCI per GEN
- TECHNETIUM TC 99M 4,500 MCI per GEN
- TECHNETIUM TC 99M 5,000 MCI per GEN
- TECHNETIUM TC 99M 6,000 MCI per GEN
- TECHNETIUM TC 99M 7,500 MCI per GEN
- TECHNETIUM TC 99M 10,000 MCI per GEN
- TECHNETIUM TC 99M 12,500 MCI per GEN
- TECHNETIUM TC 99M 15,000 MCI per GEN
- TECHNETIUM TC 99M 20,000 MCI per GEN